Terms: = Leukemia AND MAML2, MAM3, 84441, ENSG00000184384, MAM-3, MLL-MAML2, Q8IZL2, KIAA1819, DKFZp686N0150, MAM2
13 results:
1. Rearrangement of
Othman BK; Steiner P; Leivo I; Skálová A
Fetal Pediatr Pathol; 2023 Oct; 42(5):796-807. PubMed ID: 37517063
[No Abstract] [Full Text] [Related]
2. Mitotic recombinatory evolution in acute leukemia.
Papenhausen P; Kelly CA; Zhang Z; Penton A
Cancer Genet; 2023 Jun; 274-275():33-40. PubMed ID: 36966725
[TBL] [Abstract] [Full Text] [Related]
3. KMT2A-maml2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Felix CA; Slater DJ; Davenport JW; Yu X; Gregory BD; Li MM; Rappaport EF; Cheung NV
Pediatr Blood Cancer; 2022 Jan; 69(1):e29344. PubMed ID: 34550633
[TBL] [Abstract] [Full Text] [Related]
4. Inv(11)(q21q23); KMT2A-maml2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic leukemia.
Mariani RA; Silva M; Caparelli E; Jennings LJ; Yap KL; Leuer KM; Weinstein J; Gong S
J Pediatr Hematol Oncol; 2020 May; 42(4):e258-e261. PubMed ID: 31343482
[TBL] [Abstract] [Full Text] [Related]
5. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
6. First case of B ALL with KMT2A-maml2 rearrangement: a case report.
Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
[TBL] [Abstract] [Full Text] [Related]
7. Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms.
Tang G; Lu X; Wang SA; Roney EK; Zhang L; Hu S; Lu G; Medeiros LJ; Patel A
Int J Clin Exp Pathol; 2014; 7(6):3196-201. PubMed ID: 25031740
[TBL] [Abstract] [Full Text] [Related]
8. Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors.
Wächter K; Kowarz E; Marschalek R
Cancer Lett; 2014 Oct; 352(2):196-202. PubMed ID: 25016062
[TBL] [Abstract] [Full Text] [Related]
9. Translocation t(2;11) in CLL cells results in CXCR4/maml2 fusion oncogene.
Acunzo M; Romano G; Wernicke D; Balatti V; Rassenti LZ; dell'Aquila M; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2014 Jul; 124(2):259-62. PubMed ID: 24855209
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological significance of maml2 gene split in mucoepidermoid carcinoma.
Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel fusion gene MLL-maml2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23).
Nemoto N; Suzukawa K; Shimizu S; Shinagawa A; Takei N; Taki T; Hayashi Y; Kojima H; Kawakami Y; Nagasawa T
Genes Chromosomes Cancer; 2007 Sep; 46(9):813-9. PubMed ID: 17551948
[TBL] [Abstract] [Full Text] [Related]
12. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
Stenman G
Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
[TBL] [Abstract] [Full Text] [Related]
13. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract] [Full Text] [Related]
